Literature DB >> 27283234

Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization.

Rania A Hashad1, Rania A H Ishak2, Ahmed S Geneidi3, Samar Mansour4.   

Abstract

The aim of this study was to assess the feasibility of employing a novel but critical formulation pH (6.2) to encapsulate an anionic model drug (methotrexate, MTX) into chitosan(Cs)-tripolyphosphate nanoparticles(NPs). A response surface methodology using a three-level full factorial design was applied studying the effects of two independent variables namely; Cs concentration and MTX concentration. The responses investigated were the entrapment efficiency (EE%), mean hydrodynamic particle size (PS), polydispersity index (PDI) and zeta potential (ZP). In order to simultaneously optimize the series of models obtained, the desirability function approach was applied with a goal to produce high percent of MTX encapsulated into highly charged Cs-TPP NPs of homogenous optimum PS. MTX-loaded CsNPs were successfully prepared at the novel pH applied. The suggested significant models were found quadratic for EE, PS and ZP responses, while 2-factor interaction model for PDI. The optimization overlay graph showed that the maximum global desirability, D=0.856, was reached when the conditions were set at high Cs and MTX concentration. Thus, the use of such optimized conditions, at this novel pH, achieved a maximum drug EE% (73.38%) into NPs characterized by optimum PS (232.6nm), small PDI value (0.195) and highly surface charged (+18.4mV).
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Chitosan (PubChem CID:71853); Methotrexate; Methotrexate sodium (PubChem CID: 11329481); Nanoparticles; Optimization; Response surface methodology; Tripolyphosphate (PubChem CID: 24455); pH value

Mesh:

Substances:

Year:  2016        PMID: 27283234     DOI: 10.1016/j.ijbiomac.2016.06.014

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours.

Authors:  G Deepa; K C Sivakumar; T P Sajeevan
Journal:  3 Biotech       Date:  2018-11-20       Impact factor: 2.406

2.  Ferulic acid encapsulated chitosan-tripolyphosphate nanoparticles attenuate quorum sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa PAO1.

Authors:  Subhaswaraj Pattnaik; Subhashree Barik; Gangatharan Muralitharan; Siddhardha Busi
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

3.  The Synergistic Effect of Hyperthermia and Chemotherapy in Magnetite Nanomedicine-Based Lung Cancer Treatment.

Authors:  Shu-Jyuan Yang; Chung-Huan Huang; Chung-Hao Wang; Ming-Jium Shieh; Ke-Cheng Chen
Journal:  Int J Nanomedicine       Date:  2020-12-18

4.  Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment.

Authors:  Noha Ibrahim Elsherif; Abdulaziz Mohsen Al-Mahallawi; Abdelfattah Ahmed Abdelkhalek; Rehab Nabil Shamma
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

5.  Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.

Authors:  Zaina Ait Bachir; YuKun Huang; MuYe He; Lei Huang; XinYu Hou; RongJun Chen; Feng Gao
Journal:  Int J Nanomedicine       Date:  2018-09-24

6.  Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution.

Authors:  Rania A H Ishak; Nada M Mostafa; Amany O Kamel
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.